Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
152.21B
Market cap152.21B
Price-Earnings ratio
18.95
Price-Earnings ratio18.95
Dividend yield
6.67%
Dividend yield6.67%
Average volume
54.46M
Average volume54.46M
High today
$26.98
High today$26.98
Low today
$25.76
Low today$25.76
Open price
$25.88
Open price$25.88
Volume
82.95M
Volume82.95M
52 Week high
$27.69
52 Week high$27.69
52 Week low
$20.92
52 Week low$20.92

Stock Snapshot

With a market cap of 152.21B, Pfizer(PFE) trades at $26.58. The stock has a price-to-earnings ratio of 18.95 and currently yields dividends of 6.7%.

During the trading session on 2026-02-04, Pfizer(PFE) shares reached a daily high of $26.98 and a low of $25.76. At a current price of $26.58, the stock is +3.2% higher than the low and still -1.5% under the high.

Trading volume for Pfizer(PFE) stock has reached 82.95M, versus its average volume of 54.46M.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.

PFE News

Nasdaq 6h
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026

Key Points Eli Lilly has leading products in the GLP-1 space, with plans to bring pill versions of its weight loss shots to market. Pfizer is playing catch-up...

Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026
TipRanks 6h
Pfizer and BioNTech Pause modRNA Shingles Ambitions

Biontech Se Sponsored Adr (BNTX), Pfizer Inc (PFE) announced an update on their ongoing clinical study. modRNA shingles pursuit from Pfizer and BioNTech now ce...

Nasdaq 18h
Will the Market Crash in 2026? Here's What History Says and What to Do About It

Key Points There are fears that stocks are overvalued right now, and some data backs this up. This could lead to a market crash, though we can't be certain....

Will the Market Crash in 2026? Here's What History Says and What to Do About It

Analyst ratings

57%

of 28 ratings
Buy
39.3%
Hold
57.1%
Sell
3.6%

More PFE News

TipRanks 19h
Balanced Near-Term Pipeline Upside Versus Structural Profit Headwinds Keeps Pfizer at Hold

Analyst Geoff Meacham from Citi maintained a Hold rating on Pfizer and keeping the price target at $26.00. Geoff Meacham has given his Hold rating due to a com...

TipRanks 22h
Pfizer Earnings Call: Pipeline Strength Amid COVID Reset

Pfizer Inc ((PFE)) has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium Unlock hedge fund-level data and p...

Benzinga 1d
Silver Surges Over 15%; Pfizer Earnings Top Views

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Tuesday. The Dow traded down 0.19% to 49,316.23 while the NA...

Silver Surges Over 15%; Pfizer Earnings Top Views
The Motley Fool 1d
Pfizer Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. Feb. 3, 2026 at 10:00 a.m. ET Call participants Chairman and Chief Executive Officer — Albert Bourla Chief Scientific Officer —...

Pfizer Q4 2025 Earnings Call Transcript
The Motley Fool 1d
Why Pfizer Stock Dropped Today

Is Pfizer stock a buy at under 9x earnings? Yes. It is. Pfizer (PFE 3.00%) stock gave up 3.3% through 10:50 a.m. ET Tuesday despite delivering an earnings beat...

Why Pfizer Stock Dropped Today
Benzinga 1d
Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

On Tuesday, Pfizer Inc. (NYSE:PFE) shared topline data from a mid-stage study for a weight loss drug and reported fourth quarter earnings that beat consensus es...

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops
Investor's Business Daily 1d
Pfizer Dives After Reaffirming Its Modest Outlook And Providing An Obesity Update

Technology Pfizer Dives After Reaffirming Its Modest Outlook And Providing An Obesity Update Licensing Pfizer (PFE) stock toppled early Tuesday after the S&P 50...

Pfizer Dives After Reaffirming Its Modest Outlook And Providing An Obesity Update

People also own

Based on the portfolios of people who own PFE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.